GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75A50123C00053ATELERIX LIFE SCIENCES INC

Overview

Award facts

Net obligations
$68.12K
$68,115of $68.12K potential value
Outlays (paid to date)
$68.12K
$68.12K paid of $68.12K obligated$68,115
Period of performance
Sep 14, 2023 to Jul 23, 2024
Ended
Modifications
1
Latest action Jul 23, 2024
Contract type
Definitive contract
PIID 75A50123C00053

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

ATELERIX - THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO PLAN AND EXECUTE A PHASE 1A CLINICAL TRIAL (HEREAFTER REFERRED TO AS THE ?PHASE 1A TRIAL?) OF THE NOVEL SMALL MOLECULE ATLX-0199 IN 30 NORMAL HEALTHY SUBJECTS. THE GOAL OF THE CLINICAL TRIAL IS

Dates and value

Award date
Signed on Sep 14, 2023
Potential end of performance
Jul 22, 2024
Current value
$68,115Base and exercised options
Potential value (if all options are exercised)
$68,115

Obligations by fiscal year of action

  • FY2024: -$680,885 (de-obligation)
  • FY2023: $749,000

Total across 2 fiscal years: $68,115

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 23, 2024. View on USAspending · Recipient on SAM.gov

Recipient

LocationCHARLOTTESVILLE, VA
UEITD8NL4UWNVW8
CAGE code8ZNE9
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

Self-reported at the time of the action.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Office Of Assistant Secretary For Preparedness And Response
  3. OFC ASST SEC FOR PREPARENESS RES
Funded from
Public health and social services emergency fundProgram activities075-0140Federal accounts (agency financial reports)

Place of performance

Place of performance
Charlottesville, Charlottesville City, Virginia 22902-5662
Congressional district (place of performance)
VA-05As reported at the time of the action

Classification and competition

Classification

Product or service (PSC)
AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT (research and development)

Competition

Extent competed
Competed under SAPF
Solicitation procedures
Simplified acquisitionSP1
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
100

Solicitation and notices

Solicitation ID
EZ-BAA-22-100-SOL-00003(as reported)
Solicitation date
Oct 18, 2022

Contract details

Subcontracting plan
Plan not requiredB
Major program
Atelerix - proof-of-concept clinical trial for a novel respiratory stimulant
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Sep 14, 2023Base obligation at award: $749,000
Latest action
Jul 23, 2024 — Terminated for convenienceModification P00002; obligation change -$680,885
Latest substantive action
Jul 23, 2024 — Terminated for convenienceModification P00002; obligation change -$680,885
Actions by type
  • Base award1
  • Terminated for convenience1
2 actions recorded, Sep 14, 2023 to Jul 23, 2024; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
No
Simplified procedures for commercial items
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$680,885
Latest action: change in base and all options
-$680,885

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
Environmentally preferableF
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7505
Contracting office code
75A501
Transactions recorded under this award key
2

Funding

Funding agency code
7500
Funding sub-tier code
7505
Funding office code
750501
Treasury accounts
  • 075-2023/2024-0140-000
Object classes
  • 25.1: Advisory and assistance services
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression